Design, synthesis and evaluation of potential dual drugs targeting the haemoglobin degradation pathway in the malaria parasite Plasmodium falciparum
Doctoral Thesis
2006
Permanent link to this Item
Authors
Supervisors
Journal Title
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
University of Cape Town
Department
Faculty
License
Series
Abstract
For many years malaria has been a major cause of human suffering. Despite significant advances in understanding the disease and the parasite, malaria still remains one of the leading causes of morbidity and mortality, particularly in the tropics. Approximately 500 million people are afflicted and almost 3 million people die from the disease annually. Of the four causative species, Plasmodium falciparum is the most lethal. Recent trends indicate rapid emergence of drug-resistent and more virulent strains of the parasite to further intensify the problem. The choice of therapies currently available for the treatment of malaria is highly limited, and several of these may eventually be lost or compromised due to drug resistance. New antimalarial drugs with proven clinical efficacy against current drug-resistance cases of malaria including Plasmodium falciparum infections is critical to combact the disease and cope with the problem of further development or resistance.
Description
Includes bibliographical references.
Keywords
Reference:
October, N. 2006. Design, synthesis and evaluation of potential dual drugs targeting the haemoglobin degradation pathway in the malaria parasite Plasmodium falciparum. University of Cape Town.